Navigation Links
OmniGuide(R) Secures $25 Million in Funding to Support Continued Growth and New Market Penetration
Date:5/15/2008

CAMBRIDGE, Mass., May 15 /PRNewswire/ -- OmniGuide, Inc., the developer of the first and only flexible CO2 laser scalpel enabling new procedures in minimally invasive surgery, today announced the closing of a $25 million series E private equity round. Psilos Group, a healthcare venture capital and private equity firm, led the funding round which includes previous OmniGuide investors: Ray Stata, Stata Venture Partners, 3i, Argonaut Ventures, ESI, Gainesborough Investments, Jeff Swartz and Westbury Partners. Thomas Weisel Partners served as advisor and placement agent for OmniGuide.

OmniGuide's BeamPath(TM) CO2 laser fibers are the most precise optical scalpels available. Since commercially launching in late-2006, OmniGuide optical scalpels have been rapidly adopted for use in minimally invasive surgeries in the U.S. and recently in Europe. To date, OmniGuide scalpels have been used successfully in more than 3,000 surgeries for treatment of head and neck cancers, for removal of life-threatening airway papillomas in adults and children, and for hearing restoration surgeries. OmniGuide distributes its disposable scalpels through a nationwide direct sales group.

"CO2 laser light offers unique precision, safety and cost benefits to minimally invasive surgeries. Our fibers deliver, for the first time, this medically advantageous light to areas in the body that could not have been reached previously," said Yoel Fink, president and CEO of OmniGuide. "OmniGuide's BeamPath fibers are enabling superior healthcare in more than 200 hospitals nationwide and are now available in Europe. Today's investment will help fuel OmniGuide's expansion into additional clinical markets such as otology, spinal surgery, neurosurgery, gastroenterology and gynecology."

"OmniGuide is an extremely promising medical device company and we believe that the value created by its products is highly aligned with our firm's investment philosophy," said Lisa M. Suennen, co-founder and managing member at Psilos Group. "Specifically, the BeamPath fiber offers the ability to undertake such precise, tissue-sparing, minimally invasive surgery which may result in significantly reduced complications and morbidity for patients, a considerably enhanced physician experience, and potentially dramatic cost reductions and outcome improvements for a wide array of surgical procedures. This matches well with our desire to back companies that truly align the incentives of patients, payers and providers to the benefit of the overall healthcare system. We are very excited to support the company's already significant growth and excellent management team with our investment."

"We are pleased to have Psilos Group join our investing partners to help further accelerate our momentum as OmniGuide transforms into a global healthcare company," said Ray Stata, chairman of the board.

About BeamPath Precision Optical Scalpels

Surgeons have used CO2 lasers for more than 30 years due to the high-degree of precision cutting capabilities. However, the lasers were previously limited to "line-of-sight" procedures with no flexible delivery available. OmniGuide's BeamPath fiber is based on breakthrough fiber technology developed at MIT, first published in Nature and exclusively licensed to OmniGuide. This technology has enabled OmniGuide to manufacture the world's first flexible fibers for CO2 laser surgery. BeamPath fibers empower surgeons to perform delicate cutting and coagulation with minimal thermal tissue damage and ultimate maneuverability, a major advantage over traditional line-of-sight CO2 lasers. To date, BeamPath fibers have been used successfully in more than 3,000 surgical procedures.

About Psilos Group

Psilos Group has been a successful healthcare venture capital and private equity firm since its founding in 1998. With over $575M under management, Psilos focuses its investments across the healthcare services, healthcare information technology, and medical technology sectors. Psilos invests nationwide in businesses that are poised to create enduring market value by fundamentally improving the U.S. healthcare system. Psilos' portfolio companies are sustainable and high-value businesses that have a demonstrated ability to reduce the costs of healthcare delivery, improve clinical quality and advance the alignment of payer, patient and provider incentives. Psilos has offices in New York, the San Francisco Bay Area and Santa Fe, New Mexico.

About OmniGuide, Inc.

OmniGuide, Inc., is the worldwide leader in precision optical scalpels for minimally invasive surgery. OmniGuide CO2 laser fiber products are clinically targeted disposable optical scalpels optimized for specific surgical procedures. The company has recently introduced a line of fiber-enabled, portable, low-cost CO2 lasers for use in operating rooms and surgical suites. The company designs and manufactures its fiber products in Cambridge, Mass. based on multi-material photonic bandgap fiber technology exclusively licensed from MIT. The company distributes its products in the U.S. and Europe through a direct sales force. OmniGuide is committed to developing products that improve and expand surgical treatment options, enhance clinical outcomes, and reduce treatment complexity and cost.
Additional information about OmniGuide may be found at http://www.omni-guide.com

Contacts: Dana Conti or Lori Stein

Schwartz Communications

(781) 684-0770

OmniGuide@schwartz-pr.com


'/>"/>
SOURCE OmniGuide, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lisa M. Suennen Joins OmniGuide(R) Board of Directors
2. Asoyia Secures Venture Capital Funding
3. InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group
4. SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
5. Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts
6. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
7. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
8. Piedmont Pharmaceuticals Secures $8.5 Million Investment
9. IPS Secures National Contract to Deliver FOCUS Healthcare Provider Network Access to Pain Management Specialists
10. UI licensee Optherion secures $37 million in financing
11. Simplex Diabetic Supply, Inc. Secures $50 Million in Growth Equity from New Enterprise Associates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 2017 , ... March is National Kidney Month – the perfect time to ... maintaining good health. Every day, two kidneys filter about 120 to 150 quarts of ... blood, eliminating waste, regulating fluid levels and blood pressure, supporting bone health and promoting ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ?This conference will prominently feature 150+ Hospital ... President and Director, AMN Healthcare: Susan Salka , 43rd President of the United ... The Big Fight My Life In and Out of the Ring: Sugar Ray Leonard , ...
(Date:3/23/2017)... Kennett Square, PA (PRWEB) , ... March 23, 2017 , ... ... sunny days. That means many students are thinking about summer internships , which ... (or lack thereof). , The pros at Garden Media Group, a boutique public relations ...
(Date:3/23/2017)... Chatham, New Jersey (PRWEB) , ... March 23, ... ... a developer of herbal-based and non-steroidal skincare products, was awarded as winners of ... with innovation products. This competition was hosted jointly by HSN and Good Housekeeping. ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017 The ... landscape with the top five players accounting for ... These companies are Stryker Sustainability Solutions, Ethicon (Johnson ... Inc., and VANGUARD AG. Despite the high level ... is witnessing the prevalence of fierce competition among ...
(Date:3/23/2017)... , March 23, 2017 Merrimack Pharmaceuticals, ... of its first patient in a Phase 1 study ... nanotherapeutic (ADN) that encapsulates a novel taxane and targets ... overexpressed in 50-100% of many major tumor types, including ... "The initiation of this study is an important ...
(Date:3/23/2017)... , March 23, 2017 Global Colposcope Market ... on the Colposcope in Global market, especially in North ... Asia-Pacific , South America , ... report categorizes the market based on manufacturers, regions, type and application. ... Browse 190 Tables ...
Breaking Medicine Technology: